T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Onto Innovation
ONTO
$14.1B
| $323M | 0.03% |
853,306
+247,523
| +41% | +$70M |
|
377
Humana
HUM
$47.8B
| $320M | 0.03% |
806,824
+588,156
| +269% | +$167M |
|
378
iShares Core US REIT ETF
USRT
$4.31B
| $319M | 0.03% |
+4,802,136
| New | +$309M |
|
379
Columbia Banking Systems
COLB
$8.39B
| $317M | 0.03% |
9,879,006
+905,586
| +10% | +$26.9M |
|
380
Praxis Precision Medicines
PRAX
$7.84B
| $316M | 0.03% |
942,999
+312,147
| +49% | +$98.8M |
|
381
Starbucks
SBUX
$108B
| $316M | 0.03% |
3,088,443
+737,507
| +31% | +$74.3M |
|
|
SOLS
382
Solstice Advanced Materials
SOLS
$9B
| $313M | 0.03% |
3,536,625
+1,202,132
| +51% | +$99.2M |
|
383
FirstCash
FCFS
$9.43B
| $313M | 0.03% |
1,448,230
+44,204
| +3% | +$9.6M |
|
384
Toll Brothers
TOL
$12.7B
| $312M | 0.03% |
1,894,554
+1,501,709
| +382% | +$214M |
|
385
Mirum Pharmaceuticals
MIRM
$5.82B
| $311M | 0.03% |
2,655,607
+938,186
| +55% | +$94.2M |
|
386
Equifax
EFX
$17.4B
| $311M | 0.03% |
1,958,098
-655,140
| -25% | -$112M |
|
387
Assurant
AIZ
$13.1B
| $307M | 0.03% |
1,143,631
-2,883
| -0.3% | -$702K |
|
|
FIG
388
Figma
FIG
$11.1B
| $306M | 0.03% |
16,919,384
+4,400,728
| +35% | +$88.6M |
|
389
Boston Scientific
BSX
$63.7B
| $302M | 0.03% |
7,070,412
-802,956
| -10% | -$43.6M |
|
|
MRX
390
Marex Group Limited Ordinary Shares
MRX
$5.13B
| $300M | 0.03% |
4,923,341
+3,017,312
| +158% | +$166M |
|
391
CenterPoint Energy
CNP
$24.3B
| $299M | 0.03% |
6,799,567
+108,707
| +2% | +$4.66M |
|
392
Ascendis Pharma A/S
ASND
$14.8B
| $299M | 0.03% |
1,122,529
-407,816
| -27% | -$95.3M |
|
393
Jabil
JBL
$33.2B
| $299M | 0.03% |
775,385
-84,907
| -10% | -$29.3M |
|
394
United Airlines
UAL
$37B
| $299M | 0.03% |
2,197,454
+316,818
| +17% | +$32.8M |
|
395
FTI Consulting
FCN
$3.71B
| $295M | 0.03% |
1,976,549
+802,032
| +68% | +$131M |
|
396
DigitalOcean
DOCN
$16.4B
| $294M | 0.03% |
1,873,882
-591,322
| -24% | -$80M |
|
397
Ralph Lauren
RL
$21.3B
| $293M | 0.03% |
729,542
+74,796
| +11% | +$27.8M |
|
398
Nextpower Inc. Common Stock
NXT
$12.3B
| $293M | 0.03% |
2,455,745
-178,496
| -7% | -$22M |
|
399
Hartford Financial Services
HIG
$33.7B
| $292M | 0.03% |
2,206,847
-937,612
| -30% | -$125M |
|
400
Vista Energy
VIST
$7.46B
| $292M | 0.03% |
4,582,496
+396,454
| +9% | +$27.9M |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.